Immunodeficiency and Autoimmunity
Inborn errors of immunity (IEI) include primary immune deficiencies (PID) and are a group of more than 480 potentially serious chronic medical conditions. They are caused by defects in genes that control the immune system and can lead to frequent or severe infections and other chronic immunological conditions, including autoimmune problems.
ASCIA Immunoglobulin Replacement Therapy (IRT) and Subcutaneous Immunoglobulin (SCIg) information is mostly not specific for PID, and can be used by other medical specialties.
Information for Health Professionals
ASCIA Inborn Errors of Immunity (Primary Immunodeficiencies) Clinical Care Standard
ASCIA Consensus Recommendations: Vaccination with Shingrix to Prevent Shingles for Immunosuppressive Conditions and Therapies - Content currently being finalised
ASCIA Immunodeficiency e-training courses - PID, IRT, HAE
ASCIA Immunodeficiency Strategy for Australia and New Zealand
ASCIA ID Register How to access information (available to ASCIA members only)
Immunoglobulin Replacement Therapy (IRT)
ASCIA Position Statement - IRT in PID
ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT - Document currently under review
ASCIA Treatment Summary for Patients on Immunoglobulin Therapy
Subcutaneous Immunoglobulin (SCIg)
ASCIA SCIg Checklists - Nurse Competency and Patient Training
ASCIA Guide – Setting up a SCIg program in a hospital
Hereditary Angioedema (HAE)
ASCIA HAE Position Paper and Management Plan
Auotimmunity
ASCIA Position Paper - Laboratory Tests for Autoimmune Diseases
Information about Vasculitis is available at www.anzvasculitis.org/medical-professionals/
Further Information
Webpage updated November 2024